41 related articles for article (PubMed ID: 33121388)
1. Well-differentiated epithelial thyroid cancer management in the Asia Pacific region: a report and clinical practice guideline.
Sundram F; Robinson BG; Kung A; Lim-Abrahan MA; Bay NQ; Chuan LK; Chung JH; Huang SM; Hsu LC; Kamaruddin N; Cheah WK; Kim WB; Koong SS; Lin HD; Mangklabruks A; Paz-Pacheco E; Rauff A; Ladenson PW
Thyroid; 2006 May; 16(5):461-9. PubMed ID: 16756468
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration.
Galofré JC; Díez JJ; Attanasio R; Nagy EV; Negro R; Papini E; Perros P; Žarković M; Akarsu E; Alevizaki M; Ayvaz G; Bednarczuk T; Beleslin BN; Berta E; Bodor M; Borissova AM; Boyanov M; Buffet C; Burlacu MC; Dobnig H; Fadeyev V; Field BCT; Fliers E; Führer D; Hakala T; Jiskra J; Kopp P; Krebs M; Kršek M; Kužma M; Lantz M; Lazúrová I; Leenhardt L; Luchytskiy V; Puga FM; McGowan A; Metso S; Moran C; Morgunova T; Niculescu DA; Perić B; Planck T; Poiana C; Robenshtok E; Rosselet PO; Ruchala M; Riis KR; Shepelkevich A; Tronko M; Unuane D; Vardarli I; Visser WE; Vryonidou M; Younes YR; Hegedüs L
J Endocrinol Invest; 2024 Jun; ():. PubMed ID: 38878126
[TBL] [Abstract][Full Text] [Related]
3. Thyroid cancer patients satisfaction at the management outcome: an analysis of the results of a nationwide survey in 485 subjects.
Díez JJ; Galofré JC
BMC Health Serv Res; 2021 Feb; 21(1):158. PubMed ID: 33602247
[TBL] [Abstract][Full Text] [Related]
4. Barriers to the Use of Active Surveillance for Thyroid Cancer Results of a Physician Survey.
Hughes DT; Reyes-Gastelum D; Ward KC; Hamilton AS; Haymart MR
Ann Surg; 2022 Jul; 276(1):e40-e47. PubMed ID: 33074908
[TBL] [Abstract][Full Text] [Related]
5. Who's Going to Manage the Thyroid Cancer?
Chang DJ; Leung AM
J Clin Endocrinol Metab; 2020 Oct; 105(10):e3820-1. PubMed ID: 32777046
[No Abstract] [Full Text] [Related]
6. SEEDO-SEMERGEN consensus document on continuous care of obesity between Primary Care and Specialist Hospital Units 2019.
Caixàs A; Villaró M; Arraiza C; Montalvá JC; Lecube A; Fernández-García JM; Corio R; Bellido D; Llisterri JL; Tinahones FJ
Med Clin (Barc); 2020 Sep; 155(6):267.e1-267.e11. PubMed ID: 32081378
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the risk of re-recurrence in patients with persistent/recurrent thyroid carcinoma after initial reoperation.
Xu S; Li Q; Wang Z; Huang H; Wang X; Liu S; Liu J
Surgery; 2021 Apr; 169(4):837-843. PubMed ID: 33127094
[TBL] [Abstract][Full Text] [Related]
8. Risk Stratification in Pediatric Thyroid Cancer: Growing Evidence for Individualized Therapy.
Wassner AJ
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1471-e1472. PubMed ID: 33124665
[No Abstract] [Full Text] [Related]
9. Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults.
Bebb DG; Banerji S; Blais N; Desmeules P; Gill S; Grin A; Feilotter H; Hansen AR; Hyrcza M; Krzyzanowska M; Melosky B; Noujaim J; Purgina B; Ruether D; Simmons CE; Soulieres D; Torlakovic EE; Tsao MS
Curr Oncol; 2021 Jan; 28(1):523-548. PubMed ID: 33467570
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Early Transition of Low-Risk Thyroid Cancer Patients from Specialist to Primary Care.
Nguyen P; Azizi-Mehr P; Townsley C; Zahedi A
Curr Oncol; 2022 Oct; 29(10):7672-7679. PubMed ID: 36290883
[TBL] [Abstract][Full Text] [Related]
11. The development and implementation of the After Cancer Treatment Transition (ACTT) Program for survivors of cancer.
Moura S; Nguyen P; Benea A; Townsley C
Can Oncol Nurs J; 2022; 32(1):3-11. PubMed ID: 35280074
[TBL] [Abstract][Full Text] [Related]
12. [Not Available].
Moura S; Nguyen P; Benea A; Townsley C
Can Oncol Nurs J; 2022; 32(1):12-21. PubMed ID: 35280063
[TBL] [Abstract][Full Text] [Related]
13. Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study.
Papaleontiou M; Chen DW; Banerjee M; Reyes-Gastelum D; Hamilton AS; Ward KC; Haymart MR
Thyroid; 2021 Sep; 31(9):1383-1390. PubMed ID: 33779292
[No Abstract] [Full Text] [Related]
14. Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma.
Ahn D; Lee GJ; Sohn JH; Jeon JH
Head Neck; 2020 May; 42(5):1004-1013. PubMed ID: 31930773
[TBL] [Abstract][Full Text] [Related]
15. Adherence to ATA 2015 guidelines in the management of unifocal non-invasive papillary thyroid cancer: a clinical survey among endocrinologists and surgeons.
Or K; Benbassat C; Koren S; Shteinshneider M; Koren R; Cantrell D; Kummer E; Muallem Kalmovich L
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2851-2859. PubMed ID: 30229453
[TBL] [Abstract][Full Text] [Related]
16. Update on the treatment of hypothyroidism.
Jonklaas J
Curr Opin Oncol; 2016 Jan; 28(1):18-25. PubMed ID: 26544166
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement after thyroid and parathyroid surgery.
Schäffler A
Dtsch Arztebl Int; 2010 Nov; 107(47):827-34. PubMed ID: 21173898
[TBL] [Abstract][Full Text] [Related]
18. Endocrinologist-Perceived Factors Affecting the Transition of Thyroid Cancer Patients from Specialist to Primary Care Postcancer Treatment in Ontario, Canada.
Janmohamed N; Segal P; Corrado AM; Lofters A; Nguyen P; Townsley C; Zahedi A
Thyroid; 2021 Jun; 31(6):895-901. PubMed ID: 33121388
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
